Needle Stick Injury Protocol
Immediately wash the puncture site thoroughly with soap and water without squeezing or applying pressure to increase bleeding, report the incident to your supervisor within 1 hour, and seek emergency medical evaluation within 1 hour to initiate HIV post-exposure prophylaxis (PEP) if needed, as effectiveness drops dramatically after 72 hours. 1, 2
Immediate First Aid (Within Minutes)
- Wash the needle-stick site with soap and water immediately without squeezing or applying pressure to increase bleeding 3, 1, 2
- If blood splashes into eyes, nose, or mouth, flush the involved area immediately with clean water, saline, or sterile irrigants 3, 1
- Document the exact time of injury immediately, as timing is critical for PEP eligibility (must be within 72 hours) 1, 2
- Do not recap, bend, or break the needle after injury 3, 4
Immediate Reporting and Documentation (Within 1 Hour)
- Report the incident to your supervisor immediately and seek medical treatment within 1 hour 3, 1, 2
- Document the type of injury including: 3
- Date and time of exposure
- Type of device involved (hollow-bore needle carries higher risk)
- Extent of injury (deep injection vs. superficial puncture)
- Involvement of blood or other potentially infectious body fluids
- Source patient identification if possible
Source Patient Assessment (Immediate)
- Identify the source patient if possible and determine their serologic status for HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) 3, 2
- Obtain consent and test source patient as soon as possible for: 2
- HIV antibody (FDA-approved rapid testing available)
- Hepatitis B surface antigen (HBsAg)
- Hepatitis C antibody (anti-HCV)
- If source is unknown or cannot be tested, base prophylaxis decisions on the likelihood of exposure considering the source of needle and type of exposure 3, 1
Exposed Healthcare Worker Baseline Testing (Before Starting Prophylaxis)
- Obtain baseline testing for the exposed worker: 1, 2
- HIV antibody or antigen/antibody combination test
- Hepatitis B serology (anti-HBs if vaccination status unknown)
- Hepatitis C antibody (anti-HCV)
- Pregnancy test if applicable
- Complete blood count and renal/hepatic function tests
HIV Post-Exposure Prophylaxis (Within 1-2 Hours, Maximum 72 Hours)
Start PEP immediately if presentation is within 72 hours, even before confirming the source's HIV status for substantial exposures. 1, 2
- Preferred PEP regimen: Bictegravir/emtricitabine/tenofovir alafenamide (single tablet once daily) for 28 days 1, 2
- Alternative regimens: Dolutegravir plus tenofovir alafenamide or tenofovir disoproxil fumarate plus emtricitabine or lamivudine 1
- The risk of HIV transmission from a percutaneous needlestick with HIV-infected blood is approximately 0.3-0.36% (3-4 per 1,000 exposures), and PEP reduces this risk by approximately 81% when started promptly 1, 2
- Completing the full 28-day course is essential—stopping early eliminates protection 1, 2
Hepatitis B Prophylaxis (Within 24 Hours)
Follow this algorithm based on exposed worker's vaccination status and source patient's HBsAg status: 3, 5
If exposed person is unimmunized against hepatitis B:
- Source HBsAg-positive: Administer hepatitis B immune globulin (HBIG) 0.06 mL/kg intramuscularly (maximum dose: 5 mL) immediately and begin hepatitis B vaccine series 3, 5
- Source HBsAg-negative: Begin hepatitis B vaccine series 3
- Source not tested or unknown: Begin hepatitis B vaccine series 3
If exposed person was immunized and responded (anti-HBs positive):
- No treatment is necessary 3
If exposed person was immunized and did not respond (anti-HBs negative):
- Source HBsAg-positive: HBIG immediately and in 1 month, or HBIG and initiate reimmunization 3
- Source HBsAg-negative: No treatment 3
- Source not tested or unknown: If high-risk source, consider HBIG or HBIG and HBV reimmunization as for HBsAg-positive source 3
If exposed person was immunized but response is unknown:
- Source HBsAg-positive: Test exposed for anti-HBs; if positive, no treatment; if negative, 1 dose of HBIG and 1 dose of vaccine, retest exposed for anti-HBs 4-6 months later 3
The risk of HBV transmission without prophylaxis may exceed 30% after exposure to HBeAg-positive blood, making this a critical intervention. 2, 5
Hepatitis C Management
- No post-exposure prophylaxis exists for hepatitis C 1, 2
- The risk of HCV transmission is approximately 1.8% (range 0-7%) per percutaneous exposure 2
- Early identification through testing is the primary approach 1, 2
Follow-Up Testing Schedule
- 6 weeks post-exposure
- 3 months post-exposure
- 6 months post-exposure
- HCV RNA at 4-6 weeks for earlier diagnosis (optional)
- Anti-HCV at 4-6 months post-exposure
Drug toxicity monitoring during PEP: 1, 2
- Monitor every 2 weeks during the 28-day PEP course
- Perform complete blood count and renal/hepatic function tests
Precautions During Follow-Up Period (6 Months)
- Use barrier protection during sexual activity 1, 2
- Do not donate blood, plasma, organs, tissue, or semen 1, 2
- Seek immediate medical evaluation for any acute illness, which may indicate acute retroviral syndrome 1, 2
Common Pitfalls to Avoid
- Delaying wound washing: Must be done immediately, not after reporting or documentation 4
- Squeezing the wound: This does not reduce infection risk and may cause tissue damage 1, 2, 4
- Waiting for source patient results before starting PEP: Start immediately for substantial exposures, do not delay 1, 2
- Incomplete PEP course: Stopping early eliminates protection; adherence is critical 1, 2
- Recapping needles: This is the most common behavior associated with needlestick injuries and must be avoided 3, 6
Prevention Measures for Future Incidents
- Never recap, bend, or break needles or remove needles from a syringe by hand 3
- Dispose of needles immediately after use into impermeable and puncture-proof sharps containers at the point of use 3
- Use safety-engineered devices designed to reduce the risk of needle sticks 3, 4
- Ensure sharps containers are not overfilled (seal when two-thirds full or after four weeks of use) 3